AllianceBernstein
AKCA

AllianceBernstein’s Akcea Therapeutics Inc AKCA Stock Holding History

AllianceBernstein’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-43,000
Closed -$780K – 3255
2020
Q3 		$780K Sell
43,000
-8,900
-17% -$126K ﹤0.01% 2298
2020
Q2 		$711K Buy
51,900
+14,300
+38% +$221K ﹤0.01% 2393
2020
Q1 		$538K Buy
37,600
+3,300
+10% +$54.2K ﹤0.01% 2315
2019
Q4 		$581K Buy
34,300
+1,200
+4% +$22.3K ﹤0.01% 2484
2019
Q3 		$509K Hold
33,100
– – ﹤0.01% 2540
2019
Q2 		$776K Buy
33,100
+6,700
+25% +$165K ﹤0.01% 2421
2019
Q1 		$748K Sell
26,400
-2,700
-9% -$78.6K ﹤0.01% 2380
2018
Q4 		$877K Buy
29,100
+1,600
+6% +$44.9K ﹤0.01% 2251
2018
Q3 		$963K Sell
27,500
-8,900
-24% -$269K ﹤0.01% 2352
2018
Q2 		$863K Buy
36,400
+10,800
+42% +$258K ﹤0.01% 2386
2018
Q1 		$656K Buy
25,600
+6,700
+35% +$144K ﹤0.01% 2439
2017
Q4 		$328K Buy
+18,900
New +$371K ﹤0.01% 2686

AllianceBernstein's AKCA Position: Q4 2020 in Review

AllianceBernstein sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 43,000 shares — an estimated $780K sold.

AllianceBernstein first reported a position in AKCA in Q4 2017 and held it in 12 quarters. The position peaked at $963K in Q3 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • AllianceBernstein reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • AllianceBernstein sold 43,000 Akcea Therapeutics Inc shares in Q4 2020, an estimated $780K.
  • AllianceBernstein first reported a position in Akcea Therapeutics Inc in Q4 2017 and held it in 12 quarters.
  • AllianceBernstein's Akcea Therapeutics Inc position peaked at $963K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on AllianceBernstein's 13F filing for Q4 2020, filed 8 Feb 2021.